Qiagen (QGEN) news

QOEP sets up $2B sukuk program to access intl debt capital mkt

Qatar Oil and Energy Projects (QOEP) has announced plans to launch a $2 billion sukuk issuance program to access international debt capital markets, signaling a strategic move to diversify its funding sources. The initiative aligns with broader trends in the global sukuk market, which has shown…

QIAGEN N.V.: Barclays raises to overweight from equal-weight; raises target price to $55 from $40

Barclays has upgraded its rating for QIAGEN N.V. (QGEN) from equal-weight to overweight, reflecting a more favorable outlook for the life sciences tools and diagnostics company. The firm also raised its target price for the stock to $55 from $40, signaling increased confidence in QIAGEN’s growth…

QIAGEN N.V. - QIASTAT-DX system available in over 100 countries with 5,200 placements as of end 2025

QIAGEN completes U.S. QIAstat-Dx bloodstream infection portfolio with FDA clearance of new bacteria detection panel

QIAGEN has completed its U.S. QIAstat-Dx bloodstream infection testing portfolio with the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for the QIAstat-Dx BCID GPF Plus AMR Panel, first bloodstream infection panel for the U.S. market. This panel is designed to detect 20…

QIAGEN launches QiaMini to automate small-batch sample preparation

QIAGEN has announced the launch of QIAmini, a new sample preparation instrument designed to automate small-batch workflows in laboratories. The device is part of the company’s broader strategy to expand its automation portfolio across different throughput segments, following the planned 2026…